{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:39:49Z","timestamp":1760297989407},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,8,22]],"date-time":"2008-08-22T00:00:00Z","timestamp":1219363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The emergence of non\u2010Hodgkin lymphoma (NHL) during childhood and adolescence as a secondary neoplasm (SN) after previous cancer other than NHL is rare. To describe the characteristics and outcome of NHL following previous cancer other than NHL in children and adolescents, this study analysed the data of patients reported to the NHL\u2010Berlin\u2010Frankfurt\u2010M\u00fcnster study centre from 1986 to 2005. Out of the total of 2968 NHL\u2010patients registered, 11 patients were assessed as having suffered from NHL as a proven SN. Four additional children had most likely suffered from NHL as an SN, but a late relapse of the first neoplasm could not be ruled out unequivocally. In the patients with proven SN, median age at diagnosis of the primary malignancy was 3\u00b79\u2003years (range 2\u201311\u00b77). The median age at diagnosis of NHL was 7\u00b76\u2003years (range 4\u00b77\u201318). Only lymphoblastic (<jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>7) and diffuse large B\u2010cell (<jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>4) lymphomas were diagnosed as SN. The estimated 5\u2010year event\u2010free survival from time of diagnosis of NHL was 91% [95% confidence interval (CI) 74\u2013100%] in patients with proven SNs and 84% (95% CI 63\u2013100%) when the patients with probable SNs were included in the analysis. We concluded that secondary NHL in children and adolescents confers a favourable prognosis.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07356.x","type":"journal-article","created":{"date-parts":[[2008,8,22]],"date-time":"2008-08-22T14:40:49Z","timestamp":1219416049000},"page":"387-394","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Secondary non\u2010Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL"],"prefix":"10.1111","volume":"143","author":[{"given":"Eva","family":"Landmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilske","family":"Oschlies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meinolf","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Berlin\u2010Frankfurt\u2010M\u00fcnster group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,14]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.2.427"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(03)00076-4"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.12.4257"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05735.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.2707"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.10.004"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2006.08.005"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.10.2705"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.5037"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.10.2780.2780"},{"key":"e_1_2_6_12_1","first-page":"908","article-title":"Secondary non\u2010Hodgkin\u2019s lymphoma after treatment for childhood cancer","volume":"5","author":"Eguiguren J.M.","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.1031"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10833"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg755"},{"volume-title":"WHO Classification, Tumours of Haematopoietic and Lymphoid Tissue","year":"2001","author":"Jaffe E.S.","key":"e_1_2_6_16_1"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602226"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20820"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood.V95.9.2770.009k16_2770_2775","article-title":"Secondary neoplasms subsequent to Berlin\u2010Frankfurt\u2010Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy","volume":"95","author":"Loning L.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20922"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-112920"},{"key":"e_1_2_6_23_1","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non\u2010Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy S.B.","year":"1980","journal-title":"Seminars in Oncology"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.8.618"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.359"},{"key":"e_1_2_6_26_1","first-page":"3294","article-title":"Improved treatment results in childhood B\u2010cell neoplasms with tailored intensification of therapy: a report of the Berlin\u2010Frankfurt\u2010Munster Group Trial NHL\u2010BFM 90","volume":"94","author":"Reiter A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_27_1","first-page":"416","article-title":"Intensive ALL\u2010type therapy without local radiotherapy provides a 90% event\u2010free survival for children with T\u2010cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1026781"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30248-X"},{"issue":"5","key":"e_1_2_6_30_1","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1093\/annonc\/9.suppl_5.S115","article-title":"Pediatric Hodgkin\u2019s disease: treatment in the late 1990s","volume":"9","author":"Schellong G.","year":"1998","journal-title":"Annals of Oncology"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3699"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17550-8"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.3.842"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.2.329"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19901015)66:8<1703::AID-CNCR2820660809>3.0.CO;2-V"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0973"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1025352"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07356.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07356.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T10:55:11Z","timestamp":1697453711000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07356.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,14]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07356.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07356.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"type":"print","value":"0007-1048"},{"type":"electronic","value":"1365-2141"}],"subject":[],"published":{"date-parts":[[2008,10,14]]},"assertion":[{"value":"2008-10-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}